Sumitomo Pharma(FRA) DPM

Market Cap€3.51B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€8.23

+5.22%

+0.41Today

Sumitomo Pharma Financials at a Glance

Market Cap

€3.51B

Revenue (TTM)

€2.64K

Net Income (TTM)

€645.25

EPS (TTM)

€1.60

P/E Ratio

4.87

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Price

€8.23

Volume

Open

€8.23

Price

€8.23

Volume

Open

€8.23

Previous Close

€8.23

Daily Range

€8.23 - €8.23

52-Week Range

€6.65 - €18.80

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Price

€8.23

Volume

Open

€8.23

Previous Close

€8.23

Daily Range

€8.23 - €8.23

52-Week Range

€6.65 - €18.80

Estimated Earnings Date

N/A

DPM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

Industry

Pharmaceuticals

Sector

Health Care

Employees

3,123

CEO

Toru Kimura, PhD

Website

www.sumitomo-pharma.co.jp

DPM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

39.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

20.53%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€3.51B

Shares Outstanding

448.59M

Volume

Avg. Volume

15.394

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Sumitomo Pharma Performance Analysis

Sumitomo Pharma annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	EUR 3,942,496,514	-8.1%
2024	2024-03-31	EUR 2,008,925,813	-49.0%
2025	2025-03-31	EUR 2,436,890,279	21.3%
2026	2026-03-31	EUR 2,596,031,351	6.5%

Sumitomo Pharma annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	EUR -1.33	N/A
2024	2024-03-31	EUR -5.06	280.4%
2025	2025-03-31	EUR 0.36	N/A
2026	2026-03-31	EUR 1.54	323.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€698.91

+1.1%

Gross Profit

€367.45

+0.9%

Gross Margin

52.57%

+0.9%

Market Cap

€3.51B

N/A

Market Cap/Employee

€1.15

N/A

Employees

3,123

N/A

Net Income

€91.74

+1.3%

EBITDA

€120.43

+0.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.28K

-34.3%

Total Debt

€864.61

+0.5%

Accounts Receivable

€750.79

+1.5%

Inventory

€428.79

+0.8%

Long Term Debt

€643.96

+0.4%

Short Term Debt

€220.65

+0.7%

Return on Assets

14.55%

+5.7%

Return on Invested Capital

-17.51%

+0.8%

Free Cash Flow

-€43.75

+4.3%

Operating Cash Flow

-€40.17

+34.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About DPM

What is the current price of Sumitomo Pharma?

Sumitomo Pharma is trading at €8.23 per share.

What is the 52-week range for Sumitomo Pharma?

Over the past 52 weeks, Sumitomo Pharma has traded between €6.65 and €18.80.

How much debt does Sumitomo Pharma have?

As of the most recent reporting period, Sumitomo Pharma reported total debt of €864.61M.

How much cash does Sumitomo Pharma have on hand?

Sumitomo Pharma reported €412.45M in cash and cash equivalents in its most recent financial results.

What is Sumitomo Pharma’s dividend yield?

Sumitomo Pharma does not currently have a dividend yield.

Sumitomo Pharma(FRA) DPM

Sumitomo Pharma Financials at a Glance

DPM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sumitomo Pharma

DPM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sumitomo Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DPM

What is the current price of Sumitomo Pharma?

What is the 52-week range for Sumitomo Pharma?

How much debt does Sumitomo Pharma have?

How much cash does Sumitomo Pharma have on hand?

What is Sumitomo Pharma’s dividend yield?

Premium Investing Services